Pre-operative Exercise During Neoadjuvant Chemotherapy in Patients With Breast Cancer
Condition(s) studied
Investigational drug(s) / intervention(s)
Prehabilitation program: The prehabilitation program includes combined high-intensity interval training on a cycle ergometer and machine-based resistance exercise of large muscle groups supervised by a physiotherapist. Exercise sessions will take place in physiotherapy departments at local hospitals or in municipality rehabilitation centres 3 times a week during the neoadjuvant chemotherapy period and ending in the week before breast surgery (maximum estimated 29 weeks depending on number of chemotherapy cycles, dose delays and time of breast surgery). Participants will be screened for psychological distress four times and in case of moderate-severe distress be advised to visit the local Cancer Society Support Center where participants will be assessed and offered free services based on their psychosocial needs and available offers. Participation will be monitored.
Study summary
The Neo-Train study is a randomized controlled trial investigating the effects of supervised pre-operative aerobic and resistance exercise in patients with breast cancer during neoadjuvant chemotherapy.
Eligibility
Primary outcome measure(s)
- Tumour size — Sequential MRI scans follow the individual treatment plan in a period of up to 30 weeks from baseline (diagnostic MRI before start of neoadjuvant chemotherapy) to MRI performed by the end of the course of neoadjuvant chemotherapy before breast surgery.
Change in the maximum diameter of the tumour visualized by magnetic resonance imaging (MRI).
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Department of Clinical Oncology and Palliative Care, Zealand University Hospital | Næstved | Denmark |
More Zealand University Hospital trials in Denmark
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04623554 on ClinicalTrials.gov ↗ ← All trials in Denmark